Literature DB >> 2289204

Trial of anticancer immunotherapy with immobilized pokeweed mitogen: immunotherapy by extracorporeal circulation.

K Numa1, T Tani, M Kodama.   

Abstract

For the purpose of activating the immune system in the living body, we made use of pokeweed mitogen (PWM). PWM, a type of lectin, has the potential to induce anticancer cells. In order to utilize this potential and apply it to cancer therapy by hemoperfusion with PWM, the lectin is immobilized on the surface of synthetic polymer beads and these beads are packed into a minicolumn. Human peripheral lymphocytes were activated by circulatory contact stimulation through the PWM column for 1h. After circulatory contact stimulation through the column, lymphocytes were collected and used as effector cells. Cytotoxicity tests were measured by 51Cr-release assay using K-562 cells and Daudi cells for targets. This material could enhance natural killer activity and induce cytotoxicity against natural-killer-resistant Daudi cells. Lymphocytes activated by the PWM column were injected intraregionally into nude mice bearing MKN-1 tumor, and suppression of tumor growth was recognized. Anticancer activities by direct hemoperfusion treatment with a PWM minicolumn were examined in Vx2-tumor-bearing rabbits. A single treatment using the PWM column was performed 6 days after tumor inoculation. Suppression of the tumor growth was observable for 25 days. PWM minicolumns are a likely anticancer material, acting as immunomodulators.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2289204     DOI: 10.1007/bf01754209

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  21 in total

1.  Plasmapheresis in patients with disseminated cancer: clinical results and correlation with changes in serum protein. The concept of "nonspecific blocking factors".

Authors:  L Israel; R Edelstein; P Mannoni; E Radot; E M Greenspan
Journal:  Cancer       Date:  1977-12       Impact factor: 6.860

2.  Lymphokine-activated killer cells: a new approach to immunotherapy of cancer.

Authors:  S Rosenberg
Journal:  J Natl Cancer Inst       Date:  1985-10       Impact factor: 13.506

3.  Efficacy and biocompatibility of a novel anti-cancer fiber in hemoperfusion on cancer-bearing rabbits.

Authors:  T Tani; M Kodama; T Oka; K Hanasawa; K Teramoto; S Nishiumi
Journal:  Trans Am Soc Artif Intern Organs       Date:  1984

4.  Successful immunotherapy of murine experimental hepatic metastases with lymphokine-activated killer cells and recombinant interleukin 2.

Authors:  R Lafreniere; S A Rosenberg
Journal:  Cancer Res       Date:  1985-08       Impact factor: 12.701

Review 5.  [Plasmapheresis in the patients with malignant tumor].

Authors:  M Kodama; T Tani; Y Nakane
Journal:  Gan To Kagaku Ryoho       Date:  1984-07

6.  The efficacy of large volume plasma exchange in chemotherapy resistant malignancies.

Authors:  J H Beyer; P S Werner; U Kaboth; G Krieger; G A Nagel
Journal:  Int J Artif Organs       Date:  1984-01       Impact factor: 1.595

7.  [A new strategy for malignancies by direct hemoperfusion using bacterial endotoxin bounded fiber].

Authors:  T Tani
Journal:  Nihon Geka Gakkai Zasshi       Date:  1985-11

8.  Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.

Authors:  M Rosenstein; I Yron; Y Kaufmann; S A Rosenberg
Journal:  Cancer Res       Date:  1984-05       Impact factor: 12.701

9.  Protein A-independent tumoricidal responses in dogs after extracorporeal perfusion of plasma over Staphylococcus aureus.

Authors:  B R Gordon; R E Matus; S D Saal; E G MacEwen; A I Hurvitz; K H Stenzel; A L Rubin
Journal:  J Natl Cancer Inst       Date:  1983-06       Impact factor: 13.506

10.  The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo.

Authors:  J J Mulé; S Shu; S A Rosenberg
Journal:  J Immunol       Date:  1985-07       Impact factor: 5.422

View more
  1 in total

1.  Induction of antitumor activities in spleen cells from mice and rats activated with lipopolysaccharide immobilized on beads.

Authors:  H Abe; T Tani; J Shibata; M Kodama
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.